PortfoliosLab logoPortfoliosLab logo
TSLA vs. PFE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TSLA vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tesla, Inc. (TSLA) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TSLA achieves a -6.95% return, which is significantly lower than PFE's 6.63% return. Over the past 10 years, TSLA has outperformed PFE with an annualized return of 39.76%, while PFE has yielded a comparatively lower 1.92% annualized return.


TSLA

1D
-1.24%
1M
7.47%
YTD
-6.95%
6M
-7.94%
1Y
26.02%
3Y*
24.35%
5Y*
15.95%
10Y*
39.76%

PFE

1D
1.38%
1M
-1.27%
YTD
6.63%
6M
3.31%
1Y
17.51%
3Y*
-7.13%
5Y*
-3.25%
10Y*
1.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TSLA vs. PFE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TSLA
Tesla, Inc.
-6.95%11.36%62.52%101.72%-65.03%49.76%743.44%25.70%6.89%45.70%
PFE
Pfizer Inc.
6.63%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%

Correlation

The correlation between TSLA and PFE is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jun 30, 2010

0.16

Fundamentals

Market Cap

TSLA:

$1.48T

PFE:

$147.23B

EPS

TSLA:

$1.10

PFE:

$1.31

PE Ratio

TSLA:

381.15

PFE:

19.58

PEG Ratio

TSLA:

46.63

PFE:

0.35

PS Ratio

TSLA:

15.09

PFE:

2.32

PB Ratio

TSLA:

17.60

PFE:

1.63

Total Revenue (TTM)

TSLA:

$97.88B

PFE:

$63.32B

Gross Profit (TTM)

TSLA:

$18.66B

PFE:

$43.91B

EBITDA (TTM)

TSLA:

$10.48B

PFE:

$16.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TSLA vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSLA
TSLA Risk / Return Rank: 5858
Overall Rank
TSLA Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
TSLA Sortino Ratio Rank: 5656
Sortino Ratio Rank
TSLA Omega Ratio Rank: 5454
Omega Ratio Rank
TSLA Calmar Ratio Rank: 6060
Calmar Ratio Rank
TSLA Martin Ratio Rank: 6161
Martin Ratio Rank

PFE
PFE Risk / Return Rank: 6464
Overall Rank
PFE Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6161
Sortino Ratio Rank
PFE Omega Ratio Rank: 5858
Omega Ratio Rank
PFE Calmar Ratio Rank: 7070
Calmar Ratio Rank
PFE Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TSLA vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tesla, Inc. (TSLA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TSLAPFEDifference
Sharpe ratioReturn per unit of total volatility

-0.17

Sortino ratioReturn per unit of downside risk

-0.21

Omega ratioGain probability vs. loss probability

1.13

1.15

-0.02

Calmar ratioReturn relative to maximum drawdown

0.87

1.53

-0.66

Martin ratioReturn relative to average drawdown

2.05

3.15

-1.10

TSLA vs. PFE - Sharpe Ratio Comparison

The current TSLA Sharpe Ratio is 0.57, which is comparable to the PFE Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of TSLA and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TSLAPFEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.57

0.74

-0.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

-0.13

+0.40

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

0.08

+0.59

Sharpe Ratio (All Time)

Calculated using the full available price history

0.73

0.33

+0.40

Drawdowns

TSLA vs. PFE - Drawdown Comparison

The maximum TSLA drawdown since its inception was -73.63%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for TSLA and PFE.


Loading charts...

Drawdown Indicators


TSLAPFEDifference

Max Drawdown

Largest peak-to-trough decline

-73.63%

-69.24%

-4.39%

Max Drawdown (1Y)

Largest decline over 1 year

-29.93%

-11.47%

-18.46%

Max Drawdown (3Y)

Largest decline over 3 years

-53.77%

-40.75%

-13.02%

Max Drawdown (5Y)

Largest decline over 5 years

-73.63%

-58.96%

-14.67%

Max Drawdown (10Y)

Largest decline over 10 years

-73.63%

-58.96%

-14.67%

Current Drawdown

Current decline from peak

-14.58%

-46.76%

+32.18%

Average Drawdown

Average peak-to-trough decline

-22.73%

-22.89%

+0.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.80%

5.57%

+7.23%

Volatility

TSLA vs. PFE - Volatility Comparison

Tesla, Inc. (TSLA) has a higher volatility of 12.17% compared to Pfizer Inc. (PFE) at 4.28%. This indicates that TSLA's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TSLAPFEDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.17%

4.28%

+7.89%

Volatility (6M)

Calculated over the trailing 6-month period

27.31%

14.69%

+12.62%

Volatility (1Y)

Calculated over the trailing 1-year period

46.38%

23.88%

+22.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.82%

25.50%

+33.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.10%

23.88%

+35.22%

Dividends

TSLA vs. PFE - Dividend Comparison

TSLA has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.70%.


PositionTTM20252024202320222021202020192018201720162015
PFE
Pfizer Inc.
6.70%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
TSLA
Tesla, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TSLA vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Tesla, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B20222023202420252026
22.39B
14.45B
(TSLA) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

TSLA vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Tesla, Inc. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
21.1%
67.3%
Portfolio components
TSLA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported a gross profit of 4.72B and revenue of 22.39B. Therefore, the gross margin over that period was 21.1%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

TSLA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported an operating income of 941.00M and revenue of 22.39B, resulting in an operating margin of 4.2%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

TSLA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported a net income of 491.00M and revenue of 22.39B, resulting in a net margin of 2.2%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.


Frequently Asked Questions


TSLA and PFE have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TSLA has higher volatility (12.17%) compared to PFE (4.28%). In terms of maximum drawdown, TSLA dropped -73.63% vs PFE's -69.24%.

PFE currently has the higher Sharpe Ratio (0.74 vs 0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TSLA and PFE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer